In the latest session, Concentrix Corp. (NASDAQ: CNXC) closed at $64.78 down -1.57% from its previous closing price of $65.81. In other words, the price has decreased by -$1.03 from its previous closing price. On the day, 518983 shares were traded.
Ratios:
For a deeper understanding of Concentrix Corp.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.63. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 1.40 whereas as Long-Term Debt/Eq ratio is at 1.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on September 06, 2023, initiated with a Neutral rating and assigned the stock a target price of $70.
On August 24, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $120.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 30 ’24 when Fogarty Jane bought 200 shares for $89.27 per share. The transaction valued at 17,853 led to the insider holds 5,388 shares of the business.
Fogarty Jane bought 200 shares of CNXC for $15,476 on Oct 23 ’23. The EVP, Legal now owns 5,495 shares after completing the transaction at $77.38 per share. On Oct 11 ’23, another insider, POLK DENNIS, who serves as the Director of the company, sold 1,183 shares for $81.39 each. As a result, the insider received 96,284 and left with 16,293 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 4.36B and an Enterprise Value of 9.00B. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.23, and their Forward P/E ratio for the next fiscal year is 4.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.34. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.60 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at 1.27 whereas that against EBITDA is 9.03.
Stock Price History:
Over the past 52 weeks, CNXC has reached a high of $138.68, while it has fallen to a 52-week low of $64.21. The 50-Day Moving Average of the stock is 87.45, while the 200-Day Moving Average is calculated to be 84.10.
Shares Statistics:
For the past three months, CNXC has traded an average of 518.06K shares per day and 671.69k over the past ten days. A total of 65.73M shares are outstanding, with a floating share count of 47.60M. Insiders hold about 28.20% of the company’s shares, while institutions hold 65.83% stake in the company. Shares short for CNXC as of Feb 15, 2024 were 2.1M with a Short Ratio of 4.06, compared to 1.98M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.17% and a Short% of Float of 4.39%.
Dividends & Splits
According to the company, the forward annual dividend rate for CNXC is 1.16, from 1.13 in the trailing year. Against a Trailing Annual Dividend Yield of 1.71%, it implies a Forward Annual Dividend Yield of 1.87%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of $2.58 for the current quarter, with a high estimate of $2.59 and a low estimate of $2.57, while EPS last year was $2.39. The consensus estimate for the next quarter is $2.83, with high estimates of $3.13 and low estimates of $2.62.
Analysts are recommending an EPS of between $12.17 and $11.69 for the fiscal current year, implying an average EPS of $11.96. EPS for the following year is $13.31, with 4 analysts recommending between $13.82 and $12.8.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $9.68B, while the lowest revenue estimate was $9.58B, resulting in an average revenue estimate of $9.63B. In the same quarter a year ago, actual revenue was $7.11B, up 35.30% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $10.03B in the next fiscal year. The high estimate is $10.17B and the low estimate is $9.93B. The average revenue growth estimate for next year is up 4.20% from the average revenue estimate for this year.
